share_log

一周新股 | 卫龙三度递表,天齐锂业等10家正在招股中

Weekly IPOs | Wei Long submitted the list three times, and 10 companies including Tianqi Lithium are in the process of offering shares

富途資訊 ·  Jul 2, 2022 17:15  · IPO

big

This week, the Hang Seng Index rose 0.65% to 21859.79. A total of 21 new shares have been issued this week, 3 new shares have passed the hearing, 10 new shares are in the process of offering, and six new shares will be listed on the Hong Kong Stock Exchange next week.Hong Kong stock IPO after many months of silence, once again ushered in a wave of craze, the new stock market is unprecedented.

There are many bright spots for watch delivery companies this week: the world's largest travel retail operator.China waiver (601888.SH) $Supplier of "Women's Maotai" skin fillers$300896.SZ (Amy) $Once again press the listing "start button", in order to achieve "Apoch" dual listing. The highly competitive hair transplant industry ushered in the "second share of hair transplant".$Barley transplant (temporary code) (810410.HK) $

The first strand of spicy gluten this week$Weilong delicious (temporary code) (810091.HK) $$MINISO Group (09896.HK) $On the same day, it was heard by the Hong Kong Stock Exchange; it is reported that compared with the previous two prospectuses, Weilong's fund-raising amount has been halved. With many twists and turns on the road to listing, can we successfully break through this time?

In addition, the market is hotly debatedTianqi Lithium Industry (09696.HK) $$MINISO Group (09896.HK) $$Noah Holdings-S (06686.HK) $And so on 10 new shares, is currently in the hot IPO.

logo

There are 21 new stock delivery forms this week. Where:

Love beauty guestIt is the largest supplier of hyaluronic acid-based skin fillers in China. The income in 2021 is 1.448 billion yuan, the net profit is 957 million yuan, and the gross profit margin is as high as 93%, which is known as "women's Maotai".

Aimek's product portfolio covers all segments of the medical, beauty and health management market. The company has seven products that have been granted a Class III medical device registration certificate by the State Drug Administration, more than any other domestic company in the Chinese market.$300896.SZ (Amy) $At present, the total market capitalization is about 126.6 billion yuan, and the company wants to achieve dual listing.

China medium exemptionFounded in 1984, it is the world's largest and fastest-growing tourism retail operator and the only central enterprise in China authorized by the State Council to carry out tax-free business nationwide. Since the implementation of the new tax exemption policy for Hainan outlying islands in 2020China waiver (601888.SH) $The stock price rose by leaps and bounds until February 2021, when the stock price reached an all-time high of 402.78 yuan, with a market capitalization of more than 780 billion yuan, but began to encounter a "Waterloo" in the second half of 2021, and the stock price continued to decline.

The re-application, industry analysts said, may be related to factors such as the recovery of stock prices and the rising popularity of summer tourism in Hainan. According to the Ministry of Industry and Information Technology on June 29, the "asterisk" mark of the communication itinerary card has been cancelled from now on, driving a number of tourism platforms to rise in popularity.

Barley hair transplantLocated in the middle and high-end hair diagnosis and treatment group, involving consultation and diagnosis, microneedle hair implantation, hair fixation and hair care full-cycle hair diagnosis and treatment services, which is characterized by "microneedle hair transplant" technical services. In terms of income, barley hair transplant is the hair diagnosis and treatment service enterprise with the highest market share in the first-tier cities in China. At present, barley hair transplant has set up more than 30 directly operated hospitals in Beijing, Shanghai, Guangzhou, Shenzhen and other cities.

The hair transplant industry is highly fragmented, calculated according to the income generated by hair transplant medical services in 2020.Yonghe Medical (02279.HK) $With an income of 1.413 billion yuan, it accounted for 10.5% of the market share; barley hair transplant accounted for 5.3% of the market share with an income of 710 million yuan, ranking second in the industry after Yonghe.

SoulgateIts social platform Soul is the only social networking platform in China that provides user recommendations based on interest graphs. After suspending the IPO process in US stocks in 2021, Soul moved to Hong Kong stocks to sprint for the "first share of the social meta-universe". In terms of equity, Soulgate Inc. Shares accounted for 28.5%, voting rights accounted for 49.9%; major shareholder Tencent through the image framework investment (Hong Kong) limited shares accounted for 49.9%, voting rights accounted for 28.5%.

Green bamboo organismIs a high-quality and affordable provider of human vaccines and therapeutic biological agents, with independent intellectual property rights of the next generation Fab-scFv double antibody development platform Fabite and mammalian expression technology platform and biological preparation manufacturing infrastructure and capacity. Its recombinant herpes zoster vaccine will fill the domestic gap and become the first domestic company to apply for vaccine clinical research in the United States.

Quantitative science and technologyIs a leading provider of scene-based digital solutions in China, building and operating a variety of digital scenarios to help them maintain, expand and activate their end-user base by promoting consumer spending to connect scene partners and their end users. The company's two main businesses empower digital marketing and digital transactions.

According to Frost Sullivan, in terms of revenue, the company ranked eighth among Chinese scene digital solution providers in 2021 and first among performance-based scene digital solution providers, accounting for 7.2% of users.

Weitian ExpressOperate the earliest Internet platform "Road Song" in the field of highway logistics in China, mainly providing shipper enterprise solutions, large-scale three-party logistics solutions, small and medium-sized logistics solutions, truck driver solutions. A logistics ecosystem with truck drivers as the core has been built-truck drivers as the core, the front end with the "network freight" mode of operation platform, the back end continues to add a variety of post-truck services, and Kayou zone serves as the backbone of the platform.

Since its establishment, Weitian Express has received a total of 7 rounds of financing, including Ant Group, BAIC, CITIC and other well-known institutions.

Tiantu investmentTiantu is the first investment company in China to focus on consumption. From 2019 to 2021, Tiantu ranked third among all private equity investors in the number of investment projects in China's consumer industry (after Tencent Investment and Sequoia Capital). Ranked first among all consumption-focused private equity companies in the same period. The company's new third board listed shares have been suspended on May 20, with a total share capital of 520 million shares, 5 yuan per share, with a market capitalization of 2.599 billion yuan. If successfully listed, Tiantu Investment may become China's first local VC listed on the new third board and listed in Hong Kong stocks.

logo

Three new shares have been heard this week, of which:

MINISO GroupThe proposed global offering of 41.1 million shares, with a maximum offering price of 22.10 Hong Kong dollars per share, including 4.11 million shares offered by the Hong Kong Stock Exchange and 36.99 million shares offered internationally. As of July 1$MINISO Group (MNSO.US) $At $7.93 per share, the relative issue price (later reinstatement) has fallen by 60.35%.

During the fiscal year from 2019 to 2021, the company's net loss expanded from 294 million yuan to 1.429 billion yuan, with a cumulative loss of nearly 2 billion yuan in three years. MINISO Group's rapid expansion in 2021 turned the company into a profit in the first half of fiscal year 2022, with a net profit of 339 million yuan.

According to the prospectus, the net funds raised from this dual major listing will be mainly used for the expansion and upgrading of the store network.

Weilong is deliciousIt is the highest valued leisure snack enterprise in China. Previously, two tables were submitted in May 2021 and November 2021 to raise $1 billion, while this IPO plans to raise about $500m, with a reduction in previous fundraising plans.

According to the prospectus, Weilong's operating income from 2019 to 2021 was 3.385 billion yuan, 4.12 billion yuan and 4.8 billion yuan respectively, up 24.47% and 0.98% from 2020 and 2021 respectively. Weilong's revenue continues to grow, but the growth rate declines sharply. In this regard, Weilong plans to use the funds raised to expand and upgrade production facilities and supply chain system.

Deutsche Silver WorldIs a service provider in China's commercial vehicle service industry, whose business products integrate multiple links of the commercial vehicle industry chain and cover the whole life cycle of commercial vehicles. From 2019 to 2021, the company's operating income was 2.89 billion yuan, 3.263 billion yuan and 3.13 billion yuan respectively, an increase of 25.95%, 12.78% and-4.13% respectively over the same period last year.

logo

There are 10 new shares in the pipeline this week, of which:

Tianqi Lithium Industry (09696.HK) $This landing Hong Kong stocks, will achieve A + H shares listed in two places. The company owns and mines lithium minerals in Australia and produces lithium compounds and derivatives in China. According to the Wood Mackenzie report, a subsidiary of Tianqi Lithium Industry is the world's largest lithium mining operator in terms of lithium concentrate production in 2021, with a market share of 38%, and Tianqi Lithium ranks third in terms of revenue generated by lithium in 2021.

China Graphite (02237.HK) $Mainly engaged in the processing of raw graphite into flake graphite concentrate and spherical graphite. With the increasing operation of graphite by more and more emerging technologies, such as large-scale fuel cells and high-strength composites, the global demand for graphite is also increasing.

The company plans to issue 400 million shares, of which 40 million shares will be sold to the public and 360 million shares will be offered internationally at an issue price of HK $0.325 to HK $0.375 each.

$Zhongkang Holdings (02361.HK) $Mainly provide health insight solutions to meet the sales and marketing needs of customers of medical product manufacturers. These solutions are mainly based on the company's retail data, which accounts for the majority of the company's healthy big data.

$minimally invasive brain Science (02172.HK) $As of press time, it has been 1.49 times oversubscribed. The company is a pioneer and the largest Chinese company in the neurointervention medical device industry in China, and is committed to providing innovative solutions to doctors and patients. Since the first product was approved in 2004, the product portfolio has accumulated a total of 30 commercial products and candidate products.

$Shu Lang (02385.HK) $Impact the first strand of educational intelligent hardware. The company plans to issue 52 million shares worldwide, of which Hong Kong shares account for 10% and international sales account for 90%. The Hong Kong IPO share price ranges from HK $7.6 to HK $10 per share, with an admission fee of HK $4040. The company plans to raise about HK $425.5 million through Hong Kong IPO and is expected to officially enter the Hong Kong Stock Exchange on July 12.

logo

Two new shares have been listed this week, including:

$Tianyunyun (02167.HK) $It opened 0.08% lower on the first day of trading. According to previous public information, Tian Runyun publicly placed 4656 applicants, with a success rate of 90.02%.

$Weili Holdings (02372.HK) $It opened 11.11% higher on the first day of listing, and ended up 7.94% in the previous dark market, earning HK $200 per hand. According to previous public information, Weili Holdings publicly placed 6201 applicants, with a success rate of 5.39%, with 20 subscriptions firmly in one hand.

logo

Six new shares will be listed next week.

  • This week$OneConnect Financial Technology (06638.HK) $The company will be listed on the main board of the Stock Exchange in the form of "introduction". Trading in 500 shares is expected to commence on the Stock Exchange on 4 July.

The company has conducted a major listing of American depositary shares on the New York Stock Exchange and intends to conduct a proposed dual major listing on the Hong Kong Stock Exchange while maintaining the above primary listing position, which does not involve any new issue or sale of shares.

As of July 1$OneConnect Financial Technology (OCFT.US) $U. S. stocks closed at $1.83, with a total market capitalization of $721 million.

  • The largest digital chronic disease management solution provider in China$Zhiyun Health (09955.HK) $Will be listed on the Hong Kong Stock Exchange on July 6.

After the baptism of the epidemic, valuations of Internet healthcare giants Alibaba Health Information Technology and JD Health, which are listed in Hong Kong stocks, have been adjusted back sharply. In contrast, the healthy development prospect of Zhiyun, which is waiting to be listed, has also attracted the attention of the market.

According to the Frost Sullivan report, Xuanwuyun is the largest domestic smart CRM service provider in China in terms of revenue from domestic smart CRM service providers in 2021, with a market share of 13.8% in 2021, while Xuanwuyun is the second largest smart CRM service provider in China in terms of revenue from intelligent CRM service providers in 2021.

Edit / xiaohanma

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment